A cancer diagnosis is a firestorm that turns lives upside down. It may not be life-ending, but it almost always is life-changing. Few life experiences are crueler than childhood cancer, but this blatant unfairness motivates some of the best, kindest and most heartfelt medical care. Clinicians in adult oncology can learn a lot from pediatric
One of the great things about social media is how people are able to share experiences and put their messy, imperfect truth out there—posting about everything from mental health issues to grief to the reality of stretch marks and cellulite. What’s also refreshing is how many influencers are opening up about the positive influence therapy has had on their
Effective intervention can reduce medication overuse in Residential Aged Care Facilities (RACF’s), the latest University of Tasmania research shows. Led by The Wicking Dementia Research and Education Centre’s Dr. Juanita Westbury, the research published in the Medical Journal of Australia (MJA) today focuses on the results of the RedUSe (Reducing Use of Sedatives) intervention aimed
Financial strain is the single most important factor in making health care decisions for low-income individuals, who often forgo care in favor of basic needs like food and rent, researchers in UT Southwestern’s Center for Patient-Centered Outcomes Research (PCOR) found. In addition, low-income individuals are often reluctant or too embarrassed to discuss their financial hardships
After being discharged from the hospital, an older person often is admitted directly to a skilled nursing facility (SNF). SNFs specialize in the skilled care we need to recover properly. These facilities also provide the additional rehabilitation we may need before returning home. However, experts have raised concerns about the uneven quality of SNF services,
The standard of care for kidney cancer patients continues to improve. The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer. The results of the large, international clinical trial leading to the approval were just published the prestigious New England
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok